|
Delayed
Nasdaq
23:00:00 23/06/2026 +03
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.4B 5.11B 4.63B 8.69B 599B 8.74B 60.72B 23.35B 305B 23.53B 23.02B 962B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.25B 4.97B 4.5B 8.45B 582B 8.49B 59.01B 22.69B 296B 22.87B 22.37B 935B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +1.84% | ||
| 6 months | +43.52% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 17.05 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/24/26 A | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 5/1/26 A | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 3/26/26 A | Exercice | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +78.65% | +517.38% | 6.27B | |
| -0.71% | -6.35% | -4.87% | +9.03% | 45.48B | |
| +0.21% | -2.98% | +340.68% | +519.93% | 43.69B | |
| +1.74% | -2.24% | +37.28% | +21.57% | 43.09B | |
| +1.38% | -3.28% | +3.23% | +65.60% | 39.4B | |
| -1.44% | -5.26% | +8.78% | +36.85% | 31.91B | |
| +0.87% | -2.60% | - | - | 17.31B | |
| +0.75% | -0.64% | +18.07% | +110.32% | 16.4B | |
| -0.31% | -2.78% | +10.47% | +30.49% | 14.24B | |
| +1.93% | -3.55% | +74.20% | +39.37% | 13.28B | |
| Average | +0.52% | -3.61% | +62.94% | +150.06% | 27.11B | |
| Weighted average by Cap. | +0.42% | -4.35% | +73.30% | +133.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 12.92 12.24 11.09 20.81 1.43K 20.91 145.34 55.89 729.06 56.33 55.1 2.3K |
| Net income | -236M -203M -192M -174M -327M -22.52B -329M -2.28B -878M -11.46B -885M -866M -36.21B | -198M -170M -161M -146M -274M -18.87B -275M -1.91B -736M -9.6B -742M -726M -30.34B |
| Net Debt | -364M -314M -297M -269M -505M -34.81B -508M -3.53B -1.36B -17.71B -1.37B -1.34B -55.96B | -176M -152M -144M -130M -244M -16.83B -246M -1.71B -657M -8.56B -662M -647M -27.06B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
